Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions

PHASE3CompletedINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

January 10, 1997

Primary Completion Date

February 28, 2003

Conditions

Metastatic Cancer

Interventions

BIOLOGICAL

bleomycin sulfate

DRUG

doxycycline

OTHER

talc

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

North Central Cancer Treatment Group

NETWORK

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002872 - Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions | Biotech Hunter | Biotech Hunter